News
Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform
Press release: Strategic Partnership creates an end-to-end multi-omics platform for pharma, clinical research and biomarker discovery leveraging ...
Welcome to the brand new Olink company website! Please let us know if you experience any problems.
Using Olink technology for multiplex protein biomarker discovery, Prof. Teunissen’s team are analyzing data from patients treated with natalizumab ...
Press release: UPPSALA, Sweden, Aug. 31, 2021 (GLOBE NEWSWIRE) -- CellCarta and Olink Proteomics AB announced today a strategic collaboration to ...
The UK Biobank Pharma Proteomics Project (UKB-PPP Consortium) has decided to expand the ongoing proteomics study of 53,000 ...
Customers can now pre-order the next evolution of our Olink® Explore platform for high-throughput protein biomarker discovery, which ...
Olink Signature Q100 provides a new, dedicated solution for Olink panels Target 96/48 panels that will enable researchers to ...
A major study from KTH in Stockholm is the first paper to be published describing a longitudinal wellness study as ...
After the recent launch of the Olink® Explore 1536 platform as kits, one of our long-standing core facility partners ...
SelectScience have announced an Olink-sponsored article from Professor Leo Joosten on his research on COVID-19 as their drug ...